BrainTrip, a corporation founded by David Sakić and Jurij Dreo, both with science backgrounds and experts in the human brain, is working to detect signs of dementia earlier with their innovative BrainTrip Dementia Index (BDI) system. Modern science and technology combined with computer algorithms, BDI takes brainwave data quickly through non-invasive equipment and gives it a score from 1 to 100. A lower score means the possibility of early stage dementia.

Candidates visit one of the in-person testing facilities and wear a cap that comfortably measures brain activity for only a few minutes. The results are then calculated and available within a few days. An early diagnosis brings the ability for a more effective treatment plan; dementia affects more than 10% of the elderly population. Currently there is no cure for the disease, but there is a wealth of treatment options to slow the progress.

Founders David Sakic and Jurij Dreo. Source: BrainTripFounders David Sakic and Jurij Dreo. Source: BrainTrip

New and old technology combine to scan brain more thoroughly

Electroencephalography (EEG) is the technology behind the BDI science. Though it has been around for over a century, the technology had failed to reach its true potential for a long time. Advances in computing and software technology made it possible for EEG to successfully reach data that often remains hidden, deep in the brain.

The company currently operates in Malta, Slovenia, Austria, the Netherlands and Sweden. Through funding made possible by the Enterprise Europe Network, the healthcare business looks forward to expanding their prospects throughout Europe.

To contact the author of this article, email ccooney@globalspec.com